 | • レポートコード：MRC23Q37623 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のインスリン注射装置市場について調査・分析し、世界のインスリン注射装置市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（インスリンペン、インスリン針、インスリン注射器、その他）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Becton、Dickinson and Company (BD)、Eli Lilly、Novo Nordisk、Roche、Insulet Corporation、Medtronic、Tandem Diabetes Care、Ypsomed、Valeritas、Sanofi、Animas、Beta Bionics、Cellnovo、Copernicus、Dance Biopharm、Insulet、MannKind、Owen Mumford、SOOIL、West Pharmaなどが含まれています。世界のインスリン注射装置市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、インスリン注射装置市場規模を推定する際に考慮しました。本レポートは、インスリン注射装置の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、インスリン注射装置に関するビジネス上の意思決定に役立てることを目的としています。 ・インスリン注射装置市場の概要 - 製品の定義 - インスリン注射装置のタイプ別セグメント - 世界のインスリン注射装置市場規模：タイプ別分析（インスリンペン、インスリン針、インスリン注射器、その他） - インスリン注射装置の用途別セグメント - 世界のインスリン注射装置市場規模：用途別分析（病院、診療所、その他） - 世界のインスリン注射装置市場規模予測（2018年-2029年） - インスリン注射装置の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - インスリン注射装置市場の競争状況およびトレンド ・インスリン注射装置の地域別市場規模 - 北米のインスリン注射装置市場規模（2018年-2029年） - アメリカのインスリン注射装置市場規模（2018年-2029年） - ヨーロッパのインスリン注射装置市場規模（2018年-2029年） - アジア太平洋のインスリン注射装置市場規模（2018年-2029年） - 中国のインスリン注射装置市場規模（2018年-2029年） - 日本のインスリン注射装置市場規模（2018年-2029年） - 韓国のインスリン注射装置市場規模（2018年-2029年） - インドのインスリン注射装置市場規模（2018年-2029年） - オーストラリアのインスリン注射装置市場規模（2018年-2029年） - 中南米のインスリン注射装置市場規模（2018年-2029年） - 中東・アフリカのインスリン注射装置市場規模（2018年-2029年） ・タイプ別セグメント：インスリンペン、インスリン針、インスリン注射器、その他 - 世界のインスリン注射装置のタイプ別販売量（2018年-2023年） - 世界のインスリン注射装置のタイプ別売上（2018年-2023年） - 世界のインスリン注射装置のタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界のインスリン注射装置の用途別販売量（2018年-2023年） - 世界のインスリン注射装置の用途別売上（2018年-2023年） - 世界のインスリン注射装置の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Becton、Dickinson and Company (BD)、Eli Lilly、Novo Nordisk、Roche、Insulet Corporation、Medtronic、Tandem Diabetes Care、Ypsomed、Valeritas、Sanofi、Animas、Beta Bionics、Cellnovo、Copernicus、Dance Biopharm、Insulet、MannKind、Owen Mumford、SOOIL、West Pharma ・産業チェーンと販売チャネルの分析 - インスリン注射装置産業チェーン分析 - インスリン注射装置の主要原材料 - インスリン注射装置の販売チャネル - インスリン注射装置のディストリビューター - インスリン注射装置の主要顧客 ・インスリン注射装置市場ダイナミクス - インスリン注射装置の業界動向 - インスリン注射装置市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Insulin Injection Equipment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Insulin Injection Equipment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Insulin Injection Equipment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Insulin Injection Equipment include Becton, Dickinson and Company (BD), Eli Lilly, Novo Nordisk, Roche, Insulet Corporation, Medtronic, Tandem Diabetes Care and Ypsomed, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Injection Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Injection Equipment.
The Insulin Injection Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Insulin Injection Equipment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Injection Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Becton
Dickinson and Company (BD)
Eli Lilly
Novo Nordisk
Roche
Insulet Corporation
Medtronic
Tandem Diabetes Care
Ypsomed
Valeritas
Sanofi
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Insulet
MannKind
Owen Mumford
SOOIL
West Pharma
Segment by Type
Insulin Pen
Insulin Needle
Insulin Syringe
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Injection Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Injection Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Insulin Injection Equipment Market Overview
1.1 Product Overview and Scope of Insulin Injection Equipment
1.2 Insulin Injection Equipment Segment by Type
1.2.1 Global Insulin Injection Equipment Market Value Comparison by Type (2023-2029)
1.2.2 Insulin Pen
1.2.3 Insulin Needle
1.2.4 Insulin Syringe
1.2.5 Others
1.3 Insulin Injection Equipment Segment by Application
1.3.1 Global Insulin Injection Equipment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Insulin Injection Equipment Market Size Estimates and Forecasts
1.4.1 Global Insulin Injection Equipment Revenue 2018-2029
1.4.2 Global Insulin Injection Equipment Sales 2018-2029
1.4.3 Global Insulin Injection Equipment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Insulin Injection Equipment Market Competition by Manufacturers
2.1 Global Insulin Injection Equipment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Insulin Injection Equipment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Insulin Injection Equipment Average Price by Manufacturers (2018-2023)
2.4 Global Insulin Injection Equipment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Insulin Injection Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Injection Equipment, Product Type & Application
2.7 Insulin Injection Equipment Market Competitive Situation and Trends
2.7.1 Insulin Injection Equipment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Injection Equipment Players Market Share by Revenue
2.7.3 Global Insulin Injection Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Injection Equipment Retrospective Market Scenario by Region
3.1 Global Insulin Injection Equipment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Insulin Injection Equipment Global Insulin Injection Equipment Sales by Region: 2018-2029
3.2.1 Global Insulin Injection Equipment Sales by Region: 2018-2023
3.2.2 Global Insulin Injection Equipment Sales by Region: 2024-2029
3.3 Global Insulin Injection Equipment Global Insulin Injection Equipment Revenue by Region: 2018-2029
3.3.1 Global Insulin Injection Equipment Revenue by Region: 2018-2023
3.3.2 Global Insulin Injection Equipment Revenue by Region: 2024-2029
3.4 North America Insulin Injection Equipment Market Facts & Figures by Country
3.4.1 North America Insulin Injection Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Insulin Injection Equipment Sales by Country (2018-2029)
3.4.3 North America Insulin Injection Equipment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Injection Equipment Market Facts & Figures by Country
3.5.1 Europe Insulin Injection Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Insulin Injection Equipment Sales by Country (2018-2029)
3.5.3 Europe Insulin Injection Equipment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Injection Equipment Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Injection Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Insulin Injection Equipment Sales by Country (2018-2029)
3.6.3 Asia Pacific Insulin Injection Equipment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin Injection Equipment Market Facts & Figures by Country
3.7.1 Latin America Insulin Injection Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Insulin Injection Equipment Sales by Country (2018-2029)
3.7.3 Latin America Insulin Injection Equipment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Injection Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Injection Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Insulin Injection Equipment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Insulin Injection Equipment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Injection Equipment Sales by Type (2018-2029)
4.1.1 Global Insulin Injection Equipment Sales by Type (2018-2023)
4.1.2 Global Insulin Injection Equipment Sales by Type (2024-2029)
4.1.3 Global Insulin Injection Equipment Sales Market Share by Type (2018-2029)
4.2 Global Insulin Injection Equipment Revenue by Type (2018-2029)
4.2.1 Global Insulin Injection Equipment Revenue by Type (2018-2023)
4.2.2 Global Insulin Injection Equipment Revenue by Type (2024-2029)
4.2.3 Global Insulin Injection Equipment Revenue Market Share by Type (2018-2029)
4.3 Global Insulin Injection Equipment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Insulin Injection Equipment Sales by Application (2018-2029)
5.1.1 Global Insulin Injection Equipment Sales by Application (2018-2023)
5.1.2 Global Insulin Injection Equipment Sales by Application (2024-2029)
5.1.3 Global Insulin Injection Equipment Sales Market Share by Application (2018-2029)
5.2 Global Insulin Injection Equipment Revenue by Application (2018-2029)
5.2.1 Global Insulin Injection Equipment Revenue by Application (2018-2023)
5.2.2 Global Insulin Injection Equipment Revenue by Application (2024-2029)
5.2.3 Global Insulin Injection Equipment Revenue Market Share by Application (2018-2029)
5.3 Global Insulin Injection Equipment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Becton
6.1.1 Becton Corporation Information
6.1.2 Becton Description and Business Overview
6.1.3 Becton Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Becton Insulin Injection Equipment Product Portfolio
6.1.5 Becton Recent Developments/Updates
6.2 Dickinson and Company (BD)
6.2.1 Dickinson and Company (BD) Corporation Information
6.2.2 Dickinson and Company (BD) Description and Business Overview
6.2.3 Dickinson and Company (BD) Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dickinson and Company (BD) Insulin Injection Equipment Product Portfolio
6.2.5 Dickinson and Company (BD) Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Insulin Injection Equipment Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novo Nordisk Insulin Injection Equipment Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Insulin Injection Equipment Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Insulet Corporation
6.6.1 Insulet Corporation Corporation Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Insulet Corporation Insulin Injection Equipment Product Portfolio
6.6.5 Insulet Corporation Recent Developments/Updates
6.7 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Insulin Injection Equipment Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Tandem Diabetes Care
6.8.1 Tandem Diabetes Care Corporation Information
6.8.2 Tandem Diabetes Care Description and Business Overview
6.8.3 Tandem Diabetes Care Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tandem Diabetes Care Insulin Injection Equipment Product Portfolio
6.8.5 Tandem Diabetes Care Recent Developments/Updates
6.9 Ypsomed
6.9.1 Ypsomed Corporation Information
6.9.2 Ypsomed Description and Business Overview
6.9.3 Ypsomed Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ypsomed Insulin Injection Equipment Product Portfolio
6.9.5 Ypsomed Recent Developments/Updates
6.10 Valeritas
6.10.1 Valeritas Corporation Information
6.10.2 Valeritas Description and Business Overview
6.10.3 Valeritas Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Valeritas Insulin Injection Equipment Product Portfolio
6.10.5 Valeritas Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Insulin Injection Equipment Description and Business Overview
6.11.3 Sanofi Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sanofi Insulin Injection Equipment Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Animas
6.12.1 Animas Corporation Information
6.12.2 Animas Insulin Injection Equipment Description and Business Overview
6.12.3 Animas Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Animas Insulin Injection Equipment Product Portfolio
6.12.5 Animas Recent Developments/Updates
6.13 Beta Bionics
6.13.1 Beta Bionics Corporation Information
6.13.2 Beta Bionics Insulin Injection Equipment Description and Business Overview
6.13.3 Beta Bionics Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Beta Bionics Insulin Injection Equipment Product Portfolio
6.13.5 Beta Bionics Recent Developments/Updates
6.14 Cellnovo
6.14.1 Cellnovo Corporation Information
6.14.2 Cellnovo Insulin Injection Equipment Description and Business Overview
6.14.3 Cellnovo Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Cellnovo Insulin Injection Equipment Product Portfolio
6.14.5 Cellnovo Recent Developments/Updates
6.15 Copernicus
6.15.1 Copernicus Corporation Information
6.15.2 Copernicus Insulin Injection Equipment Description and Business Overview
6.15.3 Copernicus Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Copernicus Insulin Injection Equipment Product Portfolio
6.15.5 Copernicus Recent Developments/Updates
6.16 Dance Biopharm
6.16.1 Dance Biopharm Corporation Information
6.16.2 Dance Biopharm Insulin Injection Equipment Description and Business Overview
6.16.3 Dance Biopharm Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Dance Biopharm Insulin Injection Equipment Product Portfolio
6.16.5 Dance Biopharm Recent Developments/Updates
6.17 Insulet
6.17.1 Insulet Corporation Information
6.17.2 Insulet Insulin Injection Equipment Description and Business Overview
6.17.3 Insulet Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Insulet Insulin Injection Equipment Product Portfolio
6.17.5 Insulet Recent Developments/Updates
6.18 MannKind
6.18.1 MannKind Corporation Information
6.18.2 MannKind Insulin Injection Equipment Description and Business Overview
6.18.3 MannKind Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.18.4 MannKind Insulin Injection Equipment Product Portfolio
6.18.5 MannKind Recent Developments/Updates
6.19 Owen Mumford
6.19.1 Owen Mumford Corporation Information
6.19.2 Owen Mumford Insulin Injection Equipment Description and Business Overview
6.19.3 Owen Mumford Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Owen Mumford Insulin Injection Equipment Product Portfolio
6.19.5 Owen Mumford Recent Developments/Updates
6.20 SOOIL
6.20.1 SOOIL Corporation Information
6.20.2 SOOIL Insulin Injection Equipment Description and Business Overview
6.20.3 SOOIL Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.20.4 SOOIL Insulin Injection Equipment Product Portfolio
6.20.5 SOOIL Recent Developments/Updates
6.21 West Pharma
6.21.1 West Pharma Corporation Information
6.21.2 West Pharma Insulin Injection Equipment Description and Business Overview
6.21.3 West Pharma Insulin Injection Equipment Sales, Revenue and Gross Margin (2018-2023)
6.21.4 West Pharma Insulin Injection Equipment Product Portfolio
6.21.5 West Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Injection Equipment Industry Chain Analysis
7.2 Insulin Injection Equipment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Injection Equipment Production Mode & Process
7.4 Insulin Injection Equipment Sales and Marketing
7.4.1 Insulin Injection Equipment Sales Channels
7.4.2 Insulin Injection Equipment Distributors
7.5 Insulin Injection Equipment Customers
8 Insulin Injection Equipment Market Dynamics
8.1 Insulin Injection Equipment Industry Trends
8.2 Insulin Injection Equipment Market Drivers
8.3 Insulin Injection Equipment Market Challenges
8.4 Insulin Injection Equipment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
